MedPath

PharmacoPhotonics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Pilot Study to Evaluate Safety, Tolerability, and Performance of the FAST PV Technology™ in Chronic Dialysis Patients

Not Applicable
Completed
Conditions
End Stage Renal Disease
First Posted Date
2021-02-02
Last Posted Date
2023-02-08
Lead Sponsor
FAST BioMedical
Target Recruit Count
10
Registration Number
NCT04733664
Locations
🇺🇸

Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, United States

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™

Completed
Conditions
Renal Insufficiency, Chronic
Urologic Diseases
Kidney Diseases
Acute Kidney Injury
Renal Insufficiency
First Posted Date
2017-03-29
Last Posted Date
2018-12-26
Lead Sponsor
FAST BioMedical
Target Recruit Count
32
Registration Number
NCT03095391
Locations
🇺🇸

University of Alabama Birmingham, Division of Nephrology, Birmingham, Alabama, United States

🇺🇸

ICON Early Phase Services, LLC, San Antonio, Texas, United States

FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Acute Kidney Injury
First Posted Date
2013-11-07
Last Posted Date
2017-12-12
Lead Sponsor
FAST BioMedical
Target Recruit Count
33
Registration Number
NCT01978314
Locations
🇺🇸

University of Alabama Birmingham, Division of Nephrology, Birmingham, Alabama, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.